Sarah A. Egan

827 total citations
8 papers, 211 citations indexed

About

Sarah A. Egan is a scholar working on Infectious Diseases, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Sarah A. Egan has authored 8 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Clinical Biochemistry and 2 papers in Molecular Biology. Recurrent topics in Sarah A. Egan's work include Bacterial Identification and Susceptibility Testing (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). Sarah A. Egan is often cited by papers focused on Bacterial Identification and Susceptibility Testing (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). Sarah A. Egan collaborates with scholars based in Ireland, Netherlands and Denmark. Sarah A. Egan's co-authors include David C. Coleman, Gráinne I. Brennan, Brian O’Connell, Anna C. Shore, Helen Goodyear, E.H. Price, J.I. Harper, Peter J. Watson, Brenda A. McManus and Archibald L. Hoyne and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Journal of Hospital Infection and Infection Genetics and Evolution.

In The Last Decade

Sarah A. Egan

8 papers receiving 207 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah A. Egan Ireland 6 148 82 67 41 33 8 211
Shima M. Abdulgader South Africa 10 253 1.7× 142 1.7× 185 2.8× 34 0.8× 10 0.3× 16 313
Diana Zychowski United States 8 287 1.9× 160 2.0× 130 1.9× 10 0.2× 8 0.2× 17 331
Ronit Cohen‐Poradosu Israel 8 148 1.0× 51 0.6× 45 0.7× 8 0.2× 12 0.4× 15 251
Howard L. Leaf United States 5 243 1.6× 121 1.5× 130 1.9× 42 1.0× 9 0.3× 7 309
Maho Yokoyama United Kingdom 5 100 0.7× 49 0.6× 102 1.5× 39 1.0× 2 0.1× 8 172
Glenny Vasquez United States 6 346 2.3× 168 2.0× 147 2.2× 8 0.2× 13 0.4× 8 400
C Cuny Germany 8 199 1.3× 124 1.5× 110 1.6× 16 0.4× 5 0.2× 11 227
David Leyssene France 6 117 0.8× 142 1.7× 81 1.2× 59 1.4× 4 0.1× 11 275
Juan de Dios Caballero Spain 9 48 0.3× 46 0.6× 118 1.8× 64 1.6× 2 0.1× 17 234
Kévin Gaillard France 5 341 2.3× 157 1.9× 249 3.7× 12 0.3× 3 0.1× 8 379

Countries citing papers authored by Sarah A. Egan

Since Specialization
Citations

This map shows the geographic impact of Sarah A. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Egan more than expected).

Fields of papers citing papers by Sarah A. Egan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah A. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Egan. The network helps show where Sarah A. Egan may publish in the future.

Co-authorship network of co-authors of Sarah A. Egan

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah A. Egan. A scholar is included among the top collaborators of Sarah A. Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah A. Egan. Sarah A. Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kinnevey, Peter M., Sarah A. Egan, Brenda A. McManus, et al.. (2024). Protracted transmission and persistence of ST80 vancomycin-resistant Enterococcus faecium clonal complex types CT2933, CT2932 and CT1916 in a large Irish hospital: a 39-month whole-genome sequencing study. Journal of Hospital Infection. 151. 11–20. 3 indexed citations
2.
Egan, Sarah A., Anna C. Shore, Sarah Mollerup, et al.. (2021). Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland. Journal of Antimicrobial Chemotherapy. 77(2). 320–330. 30 indexed citations
3.
Egan, Sarah A., Siobhan Corcoran, Margaret A. Fitzpatrick, et al.. (2020). Hospital outbreak of linezolid-resistant and vancomycin-resistant ST80 Enterococcus faecium harbouring an optrA-encoding conjugative plasmid investigated by whole-genome sequencing. Journal of Hospital Infection. 105(4). 726–735. 35 indexed citations
4.
Smith, Peter G. & Sarah A. Egan. (2020). A review of the shortcomings in the testing methods used and reporting of data in the literature on antimicrobial susceptibility. Arrow@dit (Dublin Institute of Technology). 1 indexed citations
5.
Egan, Sarah A., Anna C. Shore, Brian O’Connell, Gráinne I. Brennan, & David C. Coleman. (2020). Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds. Journal of Antimicrobial Chemotherapy. 75(7). 1704–1711. 76 indexed citations
6.
7.
Egan, Sarah A., Helen Lynch, Céline Harmanus, et al.. (2017). PCR-ribotype distribution of Clostridium difficile in Irish pigs. Anaerobe. 48. 237–241. 17 indexed citations
8.
Goodyear, Helen, et al.. (1993). Skin microflora of atopic eczema in first time hospital attenders. Clinical and Experimental Dermatology. 18(4). 300–304. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shima M. Abdulgader Breakdown of academic impact, for papers by Diana Zychowski Breakdown of academic impact, for papers by Ronit Cohen‐Poradosu Breakdown of academic impact, for papers by Howard L. Leaf Breakdown of academic impact, for papers by Maho Yokoyama Breakdown of academic impact, for papers by Glenny Vasquez Breakdown of academic impact, for papers by C Cuny Breakdown of academic impact, for papers by David Leyssene Breakdown of academic impact, for papers by Juan de Dios Caballero Breakdown of academic impact, for papers by Kévin Gaillard
Rankless by CCL
2026